Lastest Insider Transactions Of Intellia Therapeutics, Inc. ( NTLA ) |
Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
NTLA | Intellia Therapeutics, Inc. | Goddard Glenn | EVP, Chief Financial Officer | 2021-09-07 | Sell | 3,482 | 180.12 | 627,178 | 2021-09-09 17:38:46 |
NTLA | Intellia Therapeutics, Inc. | Goddard Glenn | EVP, Chief Financial Officer | 2021-09-07 | Option Exercise | 3,482 | 14.58 | 50,768 | 2021-09-09 17:38:46 |
NTLA | Intellia Therapeutics, Inc. | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | 2021-08-30 | Sell | 97,000 | 154.83 | 15,018,054 | 2021-09-01 19:34:46 |
NTLA | Intellia Therapeutics, Inc. | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | 2021-08-30 | Option Exercise | 97,000 | 14.01 | 1,359,300 | 2021-09-01 19:34:46 |
NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | 2021-08-19 | Sell | 22,682 | 151.28 | 3,431,398 | 2021-08-20 18:12:58 |
NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | 2021-08-19 | Option Exercise | 22,682 | 13.40 | 303,939 | 2021-08-20 18:12:58 |
NTLA | Intellia Therapeutics, Inc. | Lebwohl David | EVP, Chief Medical Officer | 2021-08-09 | Sell | 2,400 | 164.05 | 393,720 | 2021-08-11 16:50:08 |
NTLA | Intellia Therapeutics, Inc. | Lebwohl David | EVP, Chief Medical Officer | 2021-08-09 | Option Exercise | 2,400 | 12.62 | 30,288 | 2021-08-11 16:50:08 |